Nanomedicine News

RSS

Nanobiosym Health RADAR Wins Top Honors at Nokia Sensing XCHALLENGE

Nanobiosym Health RADAR, a Boston-based research incubator institute led by Dr. Anita Goel, was awarded the $525,000 Grand Prize in the first competition of the Nokia Sensing XCHALLENGE for their Gene-RADAR® sensing technology that will transform the way health care is delivered by enabling personalized diagnostic testing.

4 Oct 2013

Preclinical Data Demonstrates Potent Anti-Viral Activity of TKM-Marburg Therapeutic Treatment

Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference (RNAi) therapeutics, announced today that preclinical data demonstrating potent anti-viral activity of TKM-Marburg were presented at DIA/FDA Oligonucleotide-based Therapeutics Conference taking place in Washington, DC from September 25-27, 2013 by Tekmira's Chief Scientific Officer, Dr. Ian MacLachlan.

26 Sep 2013

Nanoparticle Vaccine Developer, Novavax to Start Pandemic and Seasonal Influenza Trials in 2014

Novavax, Inc. a clinical-stage vaccine company, announced today that it is finalizing details on costs and timelines for their next round of clinical studies with the U.S. Department of Health and Human Services, Biomedical Advanced Research and Development Authority (BARDA) following successful completion of process improvement studies.

From Novavax Inc. 25 Sep 2013

Titanium Dioxide Nanotubes May Help Improve Longevity of Dental Implants

A brighter, better, longer-lasting dental implant may soon be on its way to your dentist's office.

24 Sep 2013

Inexpensive Drug Sensor with Gold Nano Domes Identifies Fluid Contents in IV Lines

Today, computerized smart systems can deliver drugs intravenously in exact volumes to hospital patients. However, these systems cannot recognize which medications are in the tubing nor can they determine the concentration of the drug in the tubing. This lack of precise information can lead to medication errors with serious consequences.

20 Sep 2013

New Nanoparticle Treatment for Gonorrhea Based on Anti-Cancer Drug

A new gonorrhea treatment, based on an anti-cancer therapy developed by a Buffalo startup company, has successfully eliminated gonococcal infection in female mice and prevented reinfection, according to research published yesterday by UB scientists in the Journal of Infectious Diseases.

20 Sep 2013

Research Opens New Window into Nanoscale Neuronal Activity

A new technique that allows scientists to measure the electrical activity in the communication junctions of the nervous systems has been developed by a researcher at Queen Mary University of London.

19 Sep 2013

Microscopic, Bottle-Like Structures can Release Drugs Inside the Body

Microscopic, bottle-like structures with corks that melt at precisely-controlled temperatures could potentially release drugs inside the body or fragrances onto the skin, according to a recently published study.

From Georgia Institute of Technology 19 Sep 2013

US Patent Office Awards Patent to Newcyte for Carbon Nanostructure Artificial Retinal Implant

The U.S. Patent Office has awarded patent no. 8,433,417 to Newcyte Inc. for a carbon nanostructure artificial retinal implant. Newcyte was purchased in 2009 by Natcore Technology Inc.

18 Sep 2013

NanoViricides Improves Broad-Spectrum Anti-HIV Nanoviricide

NanoViricides, Inc. reports that it has successfully improved upon its previous lead anti-HIV drug candidate, based on cell culture studies. An improved broad-spectrum anti-HIV nanoviricide that inhibited two distinctly different types of HIV-1 viruses equally well has been identified.

17 Sep 2013